Restructuring events
European Restructuring Monitor (ERM)
The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Teva, an Israeli pharmaceutical company, plans to cut around 150 jobs at its headquarters in Ulm and its production site in Blaubeuren-Weiler (Baden-Württemberg). 50 jobs were already cut in the spring, and a further 150 jobs are to be cut by the end of 2026.
The reason for the measure is cost-cutting targets set by the parent company in Israel and efficiency gains through automation and the use of artificial intelligence.
The jobs are to be cut mainly through termination agreements with severance payments and not filling vacant positions; redundancies are not currently planned.
The Mining, Chemical and Energy Industrial Union (IGBCE) has expressed concerns about the additional pressure on remaining employees, and the social partners have held talks on voluntary redundancy arrangements.
Teva Germany employs around 2,900 people and has sites in Ulm and Blaubeuren-Weiler.
Eurofound (2025), Teva, Internal restructuring in Germany, factsheet number 203184, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/203184.